247 related articles for article (PubMed ID: 26140983)
1. GRID and docking analyses reveal a molecular basis for flavonoid inhibition of Src family kinase activity.
Wright B; Watson KA; McGuffin LJ; Lovegrove JA; Gibbins JM
J Nutr Biochem; 2015 Nov; 26(11):1156-65. PubMed ID: 26140983
[TBL] [Abstract][Full Text] [Related]
2. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids.
Wright B; Moraes LA; Kemp CF; Mullen W; Crozier A; Lovegrove JA; Gibbins JM
Br J Pharmacol; 2010 Mar; 159(6):1312-25. PubMed ID: 20148891
[TBL] [Abstract][Full Text] [Related]
3. Conformational insights into the inhibitory mechanism of phyto-compounds against Src kinase family members implicated in psoriasis.
Sundarrajan S; Nandakumar MP; Prabhu D; Jeyaraman J; Arumugam M
J Biomol Struct Dyn; 2020 Mar; 38(5):1398-1414. PubMed ID: 30963942
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening.
Lin LG; Xie H; Li HL; Tong LJ; Tang CP; Ke CQ; Liu QF; Lin LP; Geng MY; Jiang H; Zhao WM; Ding J; Ye Y
J Med Chem; 2008 Aug; 51(15):4419-29. PubMed ID: 18610999
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors.
Dincer S; Cetin KT; Onay-Besikci A; Ölgen S
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1080-7. PubMed ID: 22957720
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex.
Khuntawee W; Rungrotmongkol T; Hannongbua S
J Chem Inf Model; 2012 Jan; 52(1):76-83. PubMed ID: 22172011
[TBL] [Abstract][Full Text] [Related]
7. Essential moieties of myricetins, quercetins and catechins for binding and inhibitory activity against α-Glucosidase.
Fu M; Shen W; Gao W; Namujia L; Yang X; Cao J; Sun L
Bioorg Chem; 2021 Oct; 115():105235. PubMed ID: 34388484
[TBL] [Abstract][Full Text] [Related]
8. Structural study of ponatinib in inhibiting SRC kinase.
Guo M; Duan Y; Dai S; Li J; Chen X; Qu L; Chen Z; Wei H; Jiang L; Chen Y
Biochem Biophys Res Commun; 2022 Apr; 598():15-19. PubMed ID: 35151199
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of dietary flavonoids on purified hepatic NADH-cytochrome b5 reductase: structure-activity relationships.
Çelik H; Koşar M
Chem Biol Interact; 2012 May; 197(2-3):103-9. PubMed ID: 22542668
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells.
van Zanden JJ; Geraets L; Wortelboer HM; van Bladeren PJ; Rietjens IM; Cnubben NH
Biochem Pharmacol; 2004 Apr; 67(8):1607-17. PubMed ID: 15041478
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations.
Zhang Y; Zhang TJ; Tu S; Zhang ZH; Meng FH
Molecules; 2020 Sep; 25(18):. PubMed ID: 32911607
[TBL] [Abstract][Full Text] [Related]
12. Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors.
Francini CM; Fallacara AL; Artusi R; Mennuni L; Calgani A; Angelucci A; Schenone S; Botta M
ChemMedChem; 2015 Dec; 10(12):2027-41. PubMed ID: 26514807
[TBL] [Abstract][Full Text] [Related]
13. Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative.
Chakraborty MP; Bhattacharyya S; Roy S; Bhattacharya I; Das R; Mukherjee A
J Biol Chem; 2021; 296():100449. PubMed ID: 33617879
[TBL] [Abstract][Full Text] [Related]
14. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition.
Agullo G; Gamet-Payrastre L; Manenti S; Viala C; Rémésy C; Chap H; Payrastre B
Biochem Pharmacol; 1997 Jun; 53(11):1649-57. PubMed ID: 9264317
[TBL] [Abstract][Full Text] [Related]
15. Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles.
Georghiou G; Kleiner RE; Pulkoski-Gross M; Liu DR; Seeliger MA
Nat Chem Biol; 2012 Feb; 8(4):366-74. PubMed ID: 22344177
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the binding of 3 flavonoids to the fat mass and obesity-associated protein by spectroscopy and molecular modeling.
Zhang L; Ren T; Wang Z; Wang R; Chang J
J Mol Recognit; 2017 Jun; 30(6):. PubMed ID: 28058739
[TBL] [Abstract][Full Text] [Related]
17. A Discovery Strategy for Selective Inhibitors of c-Src in Complex with the Focal Adhesion Kinase SH3/SH2-binding Region.
Moroco JA; Baumgartner MP; Rust HL; Choi HG; Hur W; Gray NS; Camacho CJ; Smithgall TE
Chem Biol Drug Des; 2015 Aug; 86(2):144-55. PubMed ID: 25376742
[TBL] [Abstract][Full Text] [Related]
18. Conformation-selective inhibitors reveal differences in the activation and phosphate-binding loops of the tyrosine kinases Abl and Src.
Hari SB; Perera BG; Ranjitkar P; Seeliger MA; Maly DJ
ACS Chem Biol; 2013 Dec; 8(12):2734-43. PubMed ID: 24106839
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
Gu C; Stashko MA; Puhl-Rubio AC; Chakraborty M; Chakraborty A; Frye SV; Pearce KH; Wang X; Shears SB; Wang H
J Med Chem; 2019 Feb; 62(3):1443-1454. PubMed ID: 30624931
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Biological, and Computational Evaluation of Novel 1,3,5-Substituted Indolin-2-one Derivatives as Inhibitors of Src Tyrosine Kinase.
Kilic-Kurt Z; Bakar F; Ölgen S
Arch Pharm (Weinheim); 2015 Oct; 348(10):715-29. PubMed ID: 26260414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
